| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sex Characteristics | 38 | 2024 | 2666 | 5.350 |
Why?
|
| Schizophrenia | 95 | 2023 | 6986 | 3.440 |
Why?
|
| Depressive Disorder, Major | 23 | 2024 | 4816 | 2.930 |
Why?
|
| Prenatal Exposure Delayed Effects | 18 | 2023 | 2538 | 2.490 |
Why?
|
| Psychotic Disorders | 24 | 2023 | 3278 | 2.050 |
Why?
|
| Stress, Psychological | 18 | 2024 | 4538 | 1.840 |
Why?
|
| Menopause | 7 | 2024 | 1651 | 1.780 |
Why?
|
| Growth Differentiation Factors | 5 | 2023 | 100 | 1.740 |
Why?
|
| Schizophrenic Psychology | 34 | 2016 | 1652 | 1.510 |
Why?
|
| Hypothalamus | 10 | 2021 | 1004 | 1.500 |
Why?
|
| Brain | 54 | 2024 | 27438 | 1.460 |
Why?
|
| Sex Factors | 36 | 2024 | 10647 | 1.420 |
Why?
|
| Hypothalamo-Hypophyseal System | 8 | 2018 | 705 | 1.390 |
Why?
|
| Affective Disorders, Psychotic | 7 | 2017 | 187 | 1.320 |
Why?
|
| Memory | 7 | 2024 | 2210 | 1.270 |
Why?
|
| Prefrontal Cortex | 16 | 2019 | 2251 | 1.220 |
Why?
|
| Bone Morphogenetic Proteins | 6 | 2023 | 848 | 1.180 |
Why?
|
| Pituitary-Adrenal System | 7 | 2018 | 557 | 1.140 |
Why?
|
| Hydrocortisone | 9 | 2024 | 1836 | 1.100 |
Why?
|
| Magnetic Resonance Imaging | 68 | 2024 | 36840 | 1.090 |
Why?
|
| Estradiol | 8 | 2019 | 1949 | 1.020 |
Why?
|
| Aging | 9 | 2024 | 8761 | 1.010 |
Why?
|
| Neuropsychological Tests | 37 | 2024 | 7134 | 0.990 |
Why?
|
| Vagus Nerve Stimulation | 4 | 2021 | 229 | 0.980 |
Why?
|
| Memory, Short-Term | 10 | 2019 | 1009 | 0.960 |
Why?
|
| Amygdala | 11 | 2020 | 1382 | 0.950 |
Why?
|
| Brain Mapping | 28 | 2021 | 6740 | 0.910 |
Why?
|
| Androgens | 3 | 2020 | 1285 | 0.880 |
Why?
|
| Gene Deletion | 3 | 2019 | 2674 | 0.880 |
Why?
|
| NFATC Transcription Factors | 2 | 2015 | 394 | 0.820 |
Why?
|
| Anorexia Nervosa | 5 | 2015 | 1363 | 0.820 |
Why?
|
| Affect | 6 | 2017 | 1498 | 0.820 |
Why?
|
| Verbal Learning | 5 | 2017 | 465 | 0.810 |
Why?
|
| Satiation | 2 | 2012 | 84 | 0.780 |
Why?
|
| Hippocampus | 13 | 2020 | 3783 | 0.780 |
Why?
|
| Cerebral Cortex | 10 | 2024 | 5827 | 0.760 |
Why?
|
| Pregnancy Trimester, Third | 3 | 2020 | 583 | 0.750 |
Why?
|
| Female | 178 | 2024 | 396943 | 0.730 |
Why?
|
| Hunger | 3 | 2013 | 207 | 0.720 |
Why?
|
| Reward | 8 | 2024 | 987 | 0.710 |
Why?
|
| Progesterone | 5 | 2014 | 750 | 0.700 |
Why?
|
| Cytokines | 5 | 2021 | 7449 | 0.690 |
Why?
|
| Male | 157 | 2024 | 364781 | 0.630 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2019 | 241 | 0.610 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2019 | 125 | 0.590 |
Why?
|
| Skin | 3 | 2019 | 4520 | 0.590 |
Why?
|
| Hair Follicle | 3 | 2015 | 219 | 0.580 |
Why?
|
| Adult | 138 | 2024 | 223542 | 0.580 |
Why?
|
| Schizophrenic Language | 3 | 2006 | 57 | 0.580 |
Why?
|
| gamma-Aminobutyric Acid | 5 | 2024 | 1140 | 0.570 |
Why?
|
| Pregnancy Complications | 7 | 2016 | 2969 | 0.560 |
Why?
|
| Gyrus Cinguli | 9 | 2024 | 1136 | 0.550 |
Why?
|
| Menstrual Cycle | 4 | 2010 | 542 | 0.550 |
Why?
|
| Bipolar Disorder | 9 | 2021 | 5124 | 0.550 |
Why?
|
| Fetal Hypoxia | 2 | 2011 | 30 | 0.550 |
Why?
|
| Dibenzothiazepines | 6 | 2003 | 102 | 0.540 |
Why?
|
| Family Health | 5 | 2012 | 1256 | 0.540 |
Why?
|
| Ghrelin | 2 | 2018 | 251 | 0.540 |
Why?
|
| Pregnancy | 30 | 2023 | 30179 | 0.530 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2018 | 462 | 0.530 |
Why?
|
| Leukocytes | 1 | 2024 | 2030 | 0.530 |
Why?
|
| Humans | 206 | 2024 | 768451 | 0.510 |
Why?
|
| Antipsychotic Agents | 11 | 2015 | 3077 | 0.510 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2019 | 607 | 0.510 |
Why?
|
| Adult Children | 1 | 2016 | 104 | 0.510 |
Why?
|
| Practice Management, Dental | 3 | 2002 | 15 | 0.500 |
Why?
|
| Language Disorders | 2 | 2006 | 140 | 0.500 |
Why?
|
| Cognition | 7 | 2024 | 7066 | 0.500 |
Why?
|
| Neural Pathways | 11 | 2024 | 3122 | 0.490 |
Why?
|
| Food Preferences | 2 | 2018 | 399 | 0.470 |
Why?
|
| Image Processing, Computer-Assisted | 23 | 2018 | 9066 | 0.470 |
Why?
|
| Genome | 2 | 2019 | 1749 | 0.460 |
Why?
|
| Cognition Disorders | 11 | 2017 | 3985 | 0.450 |
Why?
|
| Dependovirus | 1 | 2019 | 720 | 0.450 |
Why?
|
| Genetic Predisposition to Disease | 17 | 2021 | 18048 | 0.440 |
Why?
|
| Hematopoiesis | 2 | 2019 | 2058 | 0.430 |
Why?
|
| Hypothalamic Hormones | 2 | 2013 | 145 | 0.430 |
Why?
|
| Pituitary Hormones | 2 | 2013 | 182 | 0.430 |
Why?
|
| Intelligence | 5 | 2018 | 929 | 0.430 |
Why?
|
| New England | 8 | 2020 | 1056 | 0.430 |
Why?
|
| Calcineurin | 1 | 2014 | 236 | 0.420 |
Why?
|
| Prenatal Care | 1 | 2020 | 1159 | 0.410 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2019 | 3408 | 0.410 |
Why?
|
| Extinction, Psychological | 3 | 2011 | 371 | 0.410 |
Why?
|
| Metabolic Diseases | 1 | 2018 | 685 | 0.380 |
Why?
|
| Data Interpretation, Statistical | 2 | 2018 | 2705 | 0.380 |
Why?
|
| Lactation | 1 | 2014 | 397 | 0.380 |
Why?
|
| Prader-Willi Syndrome | 1 | 2011 | 79 | 0.360 |
Why?
|
| Cardiovascular Diseases | 4 | 2021 | 15638 | 0.360 |
Why?
|
| Fetal Development | 2 | 2013 | 771 | 0.360 |
Why?
|
| Young Adult | 44 | 2024 | 60045 | 0.360 |
Why?
|
| Multipotent Stem Cells | 1 | 2012 | 200 | 0.350 |
Why?
|
| Maternal Exposure | 2 | 2017 | 1078 | 0.350 |
Why?
|
| Stress, Physiological | 2 | 2016 | 1409 | 0.340 |
Why?
|
| Psychiatric Status Rating Scales | 23 | 2016 | 6035 | 0.340 |
Why?
|
| Middle Aged | 73 | 2024 | 223418 | 0.340 |
Why?
|
| Men | 1 | 2010 | 65 | 0.330 |
Why?
|
| Myasthenia Gravis | 3 | 2001 | 218 | 0.330 |
Why?
|
| Biomedical Research | 4 | 2021 | 3463 | 0.330 |
Why?
|
| Nerve Net | 6 | 2024 | 2362 | 0.330 |
Why?
|
| Women | 2 | 2010 | 225 | 0.330 |
Why?
|
| Appetite | 4 | 2018 | 247 | 0.320 |
Why?
|
| Nerve Fibers, Myelinated | 3 | 2013 | 953 | 0.320 |
Why?
|
| Energy Intake | 3 | 2021 | 2141 | 0.310 |
Why?
|
| Stem Cell Niche | 1 | 2012 | 348 | 0.310 |
Why?
|
| Evoked Potentials, Auditory | 3 | 2019 | 533 | 0.310 |
Why?
|
| Myostatin | 2 | 2023 | 129 | 0.310 |
Why?
|
| Case-Control Studies | 19 | 2024 | 22293 | 0.310 |
Why?
|
| Weight Gain | 2 | 2020 | 2357 | 0.310 |
Why?
|
| Alleles | 1 | 2019 | 6890 | 0.310 |
Why?
|
| Motivation | 3 | 2015 | 2034 | 0.310 |
Why?
|
| Perinatal Care | 1 | 2011 | 245 | 0.310 |
Why?
|
| Conditioning, Classical | 2 | 2011 | 370 | 0.300 |
Why?
|
| Photic Stimulation | 6 | 2014 | 2005 | 0.300 |
Why?
|
| Memory Disorders | 5 | 2024 | 1204 | 0.290 |
Why?
|
| Depression | 9 | 2021 | 8235 | 0.290 |
Why?
|
| Hormones | 2 | 2014 | 870 | 0.290 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 1892 | 0.280 |
Why?
|
| Autonomic Nervous System | 1 | 2012 | 709 | 0.270 |
Why?
|
| Child Development | 5 | 2020 | 2328 | 0.270 |
Why?
|
| Fear | 3 | 2011 | 1494 | 0.270 |
Why?
|
| Frontal Lobe | 7 | 2019 | 1427 | 0.270 |
Why?
|
| Acoustic Stimulation | 3 | 2012 | 1253 | 0.260 |
Why?
|
| Mental Recall | 5 | 2017 | 1226 | 0.260 |
Why?
|
| Oxygen | 9 | 2017 | 4269 | 0.260 |
Why?
|
| Obesity | 4 | 2021 | 13065 | 0.260 |
Why?
|
| Corpus Callosum | 3 | 2016 | 755 | 0.250 |
Why?
|
| Haloperidol | 4 | 2003 | 394 | 0.250 |
Why?
|
| Arousal | 4 | 2012 | 1182 | 0.250 |
Why?
|
| Corpus Striatum | 4 | 2024 | 1238 | 0.250 |
Why?
|
| Mothers | 5 | 2021 | 2210 | 0.250 |
Why?
|
| Stress Disorders, Traumatic | 1 | 2005 | 50 | 0.250 |
Why?
|
| Limbic System | 5 | 2019 | 423 | 0.250 |
Why?
|
| Pirenzepine | 2 | 2002 | 116 | 0.240 |
Why?
|
| Postprandial Period | 5 | 2013 | 319 | 0.240 |
Why?
|
| Hypertension | 2 | 2022 | 8611 | 0.240 |
Why?
|
| Event-Related Potentials, P300 | 3 | 2014 | 149 | 0.240 |
Why?
|
| Neurosecretory Systems | 1 | 2006 | 223 | 0.240 |
Why?
|
| Reproduction | 2 | 2019 | 646 | 0.240 |
Why?
|
| Stem Cells | 2 | 2015 | 3538 | 0.230 |
Why?
|
| England | 2 | 2023 | 533 | 0.230 |
Why?
|
| Schizotypal Personality Disorder | 4 | 2003 | 289 | 0.230 |
Why?
|
| Image Interpretation, Computer-Assisted | 4 | 2016 | 3408 | 0.230 |
Why?
|
| Diffusion Tensor Imaging | 8 | 2019 | 2427 | 0.230 |
Why?
|
| Brain Stem | 2 | 2020 | 862 | 0.230 |
Why?
|
| Alzheimer Disease | 3 | 2021 | 8721 | 0.230 |
Why?
|
| Interpersonal Relations | 4 | 2013 | 1439 | 0.220 |
Why?
|
| Temporal Lobe | 6 | 2014 | 1728 | 0.220 |
Why?
|
| Attention | 8 | 2014 | 2423 | 0.220 |
Why?
|
| Weight Loss | 3 | 2021 | 2710 | 0.220 |
Why?
|
| Risk Factors | 22 | 2023 | 74915 | 0.220 |
Why?
|
| Adolescent | 41 | 2024 | 89168 | 0.210 |
Why?
|
| Research Design | 2 | 2018 | 6217 | 0.210 |
Why?
|
| Anxiety | 7 | 2021 | 4655 | 0.210 |
Why?
|
| Comorbidity | 5 | 2021 | 10601 | 0.210 |
Why?
|
| Feeding Behavior | 5 | 2021 | 3202 | 0.210 |
Why?
|
| Receptors, Opioid, kappa | 1 | 2024 | 138 | 0.210 |
Why?
|
| Receptors, Opioid, mu | 1 | 2024 | 171 | 0.210 |
Why?
|
| Gonads | 2 | 2016 | 109 | 0.200 |
Why?
|
| Women's Health | 3 | 2020 | 2079 | 0.200 |
Why?
|
| Functional Laterality | 7 | 2006 | 2268 | 0.200 |
Why?
|
| Dental Enamel | 1 | 2021 | 61 | 0.190 |
Why?
|
| Psychomotor Performance | 4 | 2014 | 1894 | 0.190 |
Why?
|
| Rhode Island | 3 | 2011 | 353 | 0.190 |
Why?
|
| Sulfurtransferases | 1 | 2021 | 17 | 0.190 |
Why?
|
| Cell Differentiation | 1 | 2019 | 11674 | 0.190 |
Why?
|
| Intelligence Tests | 4 | 2015 | 505 | 0.190 |
Why?
|
| Executive Function | 2 | 2022 | 1402 | 0.190 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 2 | 2020 | 170 | 0.180 |
Why?
|
| Parahippocampal Gyrus | 2 | 2016 | 118 | 0.180 |
Why?
|
| Life Change Events | 1 | 2005 | 964 | 0.180 |
Why?
|
| Animals | 23 | 2023 | 169418 | 0.170 |
Why?
|
| Statistics as Topic | 5 | 2016 | 2362 | 0.170 |
Why?
|
| Parents | 2 | 2013 | 3596 | 0.170 |
Why?
|
| Men's Health | 1 | 2020 | 75 | 0.170 |
Why?
|
| Delusions | 4 | 2015 | 301 | 0.170 |
Why?
|
| Vagus Nerve | 2 | 2020 | 460 | 0.170 |
Why?
|
| Keratinocytes | 2 | 2015 | 879 | 0.170 |
Why?
|
| Mood Disorders | 1 | 2006 | 1128 | 0.170 |
Why?
|
| Cholinergic Antagonists | 1 | 2000 | 167 | 0.170 |
Why?
|
| Bone Development | 1 | 2023 | 473 | 0.170 |
Why?
|
| Cohort Studies | 18 | 2020 | 41797 | 0.170 |
Why?
|
| Dental Staff | 1 | 1999 | 14 | 0.160 |
Why?
|
| Mice, Inbred mdx | 1 | 2019 | 90 | 0.160 |
Why?
|
| Gender Identity | 3 | 2018 | 769 | 0.160 |
Why?
|
| Endothelial Cells | 2 | 2023 | 3586 | 0.160 |
Why?
|
| Task Performance and Analysis | 5 | 2016 | 771 | 0.160 |
Why?
|
| Child Behavior Disorders | 2 | 2017 | 813 | 0.160 |
Why?
|
| Risk | 10 | 2019 | 9642 | 0.160 |
Why?
|
| Longitudinal Studies | 9 | 2021 | 14766 | 0.160 |
Why?
|
| Reminder Systems | 1 | 2002 | 386 | 0.160 |
Why?
|
| Postmenopause | 2 | 2018 | 2519 | 0.160 |
Why?
|
| Oxytocin | 2 | 2013 | 402 | 0.160 |
Why?
|
| Employee Performance Appraisal | 1 | 1999 | 86 | 0.150 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2021 | 263 | 0.150 |
Why?
|
| Skin Neoplasms | 2 | 2015 | 5891 | 0.150 |
Why?
|
| Child of Impaired Parents | 2 | 2013 | 463 | 0.150 |
Why?
|
| Telomere | 1 | 2024 | 943 | 0.150 |
Why?
|
| Appointments and Schedules | 1 | 2002 | 443 | 0.150 |
Why?
|
| Hyperphagia | 1 | 2018 | 139 | 0.150 |
Why?
|
| Social Environment | 4 | 1992 | 1026 | 0.150 |
Why?
|
| Tryptophan | 1 | 2019 | 483 | 0.140 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2021 | 665 | 0.140 |
Why?
|
| Brain Chemistry | 1 | 2001 | 962 | 0.140 |
Why?
|
| Age Factors | 13 | 2019 | 18478 | 0.140 |
Why?
|
| Signal Transduction | 5 | 2014 | 23638 | 0.140 |
Why?
|
| Women's Health Services | 1 | 2017 | 88 | 0.140 |
Why?
|
| Prolactin | 2 | 2014 | 626 | 0.140 |
Why?
|
| Demyelinating Diseases | 2 | 1997 | 359 | 0.140 |
Why?
|
| Mice, Knockout | 5 | 2019 | 14480 | 0.140 |
Why?
|
| Mental Disorders | 6 | 2020 | 6879 | 0.140 |
Why?
|
| Integrases | 1 | 2019 | 520 | 0.140 |
Why?
|
| Adrenal Glands | 1 | 2019 | 557 | 0.140 |
Why?
|
| Polyradiculoneuropathy | 1 | 1996 | 65 | 0.130 |
Why?
|
| Heart Rate | 3 | 2020 | 4218 | 0.130 |
Why?
|
| Child | 21 | 2021 | 80863 | 0.130 |
Why?
|
| Military Personnel | 1 | 2005 | 1264 | 0.130 |
Why?
|
| Huntington Disease | 1 | 2003 | 1145 | 0.130 |
Why?
|
| Spinal Nerve Roots | 1 | 1996 | 122 | 0.130 |
Why?
|
| Gonadotropins | 1 | 2017 | 241 | 0.130 |
Why?
|
| Factor Analysis, Statistical | 3 | 2016 | 1007 | 0.130 |
Why?
|
| Language Tests | 2 | 2006 | 193 | 0.130 |
Why?
|
| Food | 2 | 2018 | 770 | 0.130 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2015 | 58 | 0.130 |
Why?
|
| Genes, Reporter | 1 | 2019 | 1525 | 0.130 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 2015 | 41 | 0.130 |
Why?
|
| Lateral Ventricles | 1 | 2016 | 145 | 0.130 |
Why?
|
| Dominance, Cerebral | 4 | 2006 | 624 | 0.130 |
Why?
|
| Caudate Nucleus | 2 | 2016 | 391 | 0.130 |
Why?
|
| Maternal Age | 1 | 2018 | 809 | 0.130 |
Why?
|
| Myelin Sheath | 1 | 2019 | 653 | 0.120 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2019 | 2181 | 0.120 |
Why?
|
| Learning | 3 | 2024 | 1762 | 0.120 |
Why?
|
| Psychological Tests | 2 | 2017 | 643 | 0.120 |
Why?
|
| Phonetics | 2 | 2006 | 204 | 0.120 |
Why?
|
| Socioeconomic Factors | 5 | 2018 | 7863 | 0.120 |
Why?
|
| Analysis of Variance | 10 | 2016 | 6242 | 0.120 |
Why?
|
| Interleukin-8 | 1 | 2018 | 705 | 0.120 |
Why?
|
| Homozygote | 1 | 2019 | 1779 | 0.120 |
Why?
|
| Mice | 10 | 2023 | 82045 | 0.120 |
Why?
|
| Respiratory Mechanics | 1 | 2019 | 722 | 0.120 |
Why?
|
| Myeloid Cells | 1 | 2019 | 833 | 0.120 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 2013 | 619 | 0.120 |
Why?
|
| Papilloma | 1 | 2015 | 142 | 0.120 |
Why?
|
| Receptors, Prolactin | 1 | 2014 | 16 | 0.120 |
Why?
|
| Prospective Studies | 11 | 2023 | 54914 | 0.120 |
Why?
|
| Gastrectomy | 1 | 2019 | 696 | 0.120 |
Why?
|
| Premenopause | 1 | 2018 | 1039 | 0.120 |
Why?
|
| Rest | 1 | 2019 | 952 | 0.120 |
Why?
|
| Social Adjustment | 4 | 2010 | 636 | 0.120 |
Why?
|
| Acylation | 1 | 2014 | 98 | 0.120 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2015 | 826 | 0.120 |
Why?
|
| Nerve Degeneration | 2 | 2012 | 750 | 0.110 |
Why?
|
| Interleukin-10 | 2 | 2018 | 1185 | 0.110 |
Why?
|
| Health Maintenance Organizations | 1 | 1997 | 658 | 0.110 |
Why?
|
| Green Fluorescent Proteins | 1 | 2019 | 2072 | 0.110 |
Why?
|
| Parietal Lobe | 3 | 2013 | 866 | 0.110 |
Why?
|
| Gene Transfer Techniques | 1 | 2019 | 1209 | 0.110 |
Why?
|
| Genetic Engineering | 1 | 2019 | 936 | 0.110 |
Why?
|
| Glutamic Acid | 1 | 2019 | 1192 | 0.110 |
Why?
|
| Cross-Sectional Studies | 9 | 2018 | 26351 | 0.110 |
Why?
|
| Family | 5 | 2007 | 3208 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 4 | 2019 | 22365 | 0.110 |
Why?
|
| Reference Values | 8 | 2006 | 4941 | 0.110 |
Why?
|
| Respiration | 1 | 2020 | 1667 | 0.110 |
Why?
|
| STAT5 Transcription Factor | 1 | 2014 | 268 | 0.110 |
Why?
|
| Fathers | 3 | 2011 | 377 | 0.110 |
Why?
|
| Sex Chromosomes | 1 | 2013 | 101 | 0.110 |
Why?
|
| Carcinogens | 1 | 2015 | 455 | 0.110 |
Why?
|
| Spinal Stenosis | 1 | 1996 | 261 | 0.110 |
Why?
|
| Sex Differentiation | 2 | 2006 | 73 | 0.110 |
Why?
|
| Infant, Newborn | 5 | 2020 | 26395 | 0.110 |
Why?
|
| Primary Prevention | 1 | 2021 | 1189 | 0.110 |
Why?
|
| Child, Preschool | 11 | 2020 | 42623 | 0.110 |
Why?
|
| Neuroprotective Agents | 1 | 2019 | 960 | 0.110 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2019 | 843 | 0.110 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2015 | 269 | 0.110 |
Why?
|
| Thalamus | 4 | 2007 | 1051 | 0.110 |
Why?
|
| Anorexia | 1 | 2013 | 152 | 0.110 |
Why?
|
| Phenotype | 9 | 2021 | 16712 | 0.100 |
Why?
|
| Janus Kinases | 1 | 2014 | 253 | 0.100 |
Why?
|
| Birth Injuries | 3 | 2015 | 151 | 0.100 |
Why?
|
| Affective Symptoms | 1 | 1995 | 418 | 0.100 |
Why?
|
| Ligands | 1 | 2019 | 3281 | 0.100 |
Why?
|
| Neurologic Examination | 1 | 2015 | 916 | 0.100 |
Why?
|
| Anisotropy | 5 | 2015 | 1296 | 0.100 |
Why?
|
| Multifactorial Inheritance | 1 | 2021 | 1421 | 0.100 |
Why?
|
| Semantics | 2 | 2006 | 617 | 0.100 |
Why?
|
| Parvalbumins | 1 | 2014 | 261 | 0.100 |
Why?
|
| Birth Weight | 1 | 2020 | 2117 | 0.100 |
Why?
|
| Electroencephalography | 5 | 2014 | 6309 | 0.100 |
Why?
|
| Psychophysics | 3 | 2011 | 291 | 0.100 |
Why?
|
| Pilot Projects | 6 | 2018 | 8730 | 0.100 |
Why?
|
| Steroids | 1 | 2017 | 937 | 0.100 |
Why?
|
| Testosterone | 2 | 2014 | 2493 | 0.100 |
Why?
|
| Infant | 7 | 2017 | 36497 | 0.100 |
Why?
|
| Bayes Theorem | 2 | 2018 | 2358 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2021 | 16029 | 0.100 |
Why?
|
| Pyramidal Cells | 1 | 2014 | 367 | 0.100 |
Why?
|
| Evoked Potentials, Visual | 1 | 2014 | 420 | 0.100 |
Why?
|
| Publishing | 1 | 1998 | 836 | 0.090 |
Why?
|
| Genome-Wide Association Study | 2 | 2021 | 12774 | 0.090 |
Why?
|
| Cyclosporine | 1 | 2014 | 780 | 0.090 |
Why?
|
| Inheritance Patterns | 1 | 2013 | 341 | 0.090 |
Why?
|
| Bacterial Infections | 1 | 2019 | 1397 | 0.090 |
Why?
|
| Muscle Cells | 1 | 2012 | 195 | 0.090 |
Why?
|
| Skin Physiological Phenomena | 1 | 2012 | 194 | 0.090 |
Why?
|
| Environment | 2 | 2010 | 1126 | 0.090 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2014 | 507 | 0.090 |
Why?
|
| Bariatric Surgery | 2 | 2019 | 1007 | 0.090 |
Why?
|
| Glycemic Index | 1 | 2013 | 400 | 0.090 |
Why?
|
| Severity of Illness Index | 9 | 2019 | 15965 | 0.090 |
Why?
|
| Residential Facilities | 1 | 1990 | 42 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2020 | 4362 | 0.090 |
Why?
|
| Follow-Up Studies | 15 | 2019 | 39430 | 0.090 |
Why?
|
| Genetic Loci | 1 | 2019 | 2630 | 0.090 |
Why?
|
| Myocytes, Cardiac | 1 | 2019 | 1683 | 0.090 |
Why?
|
| Regional Blood Flow | 1 | 2013 | 1502 | 0.080 |
Why?
|
| Logistic Models | 3 | 2015 | 13324 | 0.080 |
Why?
|
| Leukoencephalopathies | 1 | 2013 | 261 | 0.080 |
Why?
|
| Paternal Age | 1 | 2009 | 87 | 0.080 |
Why?
|
| Virus Diseases | 1 | 2015 | 723 | 0.080 |
Why?
|
| Cerebellar Ataxia | 1 | 1990 | 151 | 0.080 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2024 | 3783 | 0.080 |
Why?
|
| Melanocytes | 1 | 2012 | 512 | 0.080 |
Why?
|
| Obesity, Morbid | 1 | 2019 | 1309 | 0.080 |
Why?
|
| Prevalence | 3 | 2018 | 15880 | 0.080 |
Why?
|
| Aged | 24 | 2017 | 171520 | 0.080 |
Why?
|
| Caregivers | 1 | 2021 | 2302 | 0.080 |
Why?
|
| Statistics, Nonparametric | 3 | 2017 | 2863 | 0.080 |
Why?
|
| Enzyme Activation | 1 | 2014 | 3594 | 0.070 |
Why?
|
| Organ Size | 4 | 2018 | 2268 | 0.070 |
Why?
|
| Cadherins | 1 | 2012 | 906 | 0.070 |
Why?
|
| Muscle, Skeletal | 1 | 2023 | 4984 | 0.070 |
Why?
|
| Incidence | 4 | 2018 | 21552 | 0.070 |
Why?
|
| Attitude to Health | 2 | 2004 | 2030 | 0.070 |
Why?
|
| Boston | 2 | 2011 | 9361 | 0.070 |
Why?
|
| Aminolevulinic Acid | 1 | 2008 | 150 | 0.070 |
Why?
|
| Housing | 2 | 1990 | 679 | 0.070 |
Why?
|
| Atrophy | 3 | 2003 | 1648 | 0.070 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 2785 | 0.070 |
Why?
|
| Cell Movement | 1 | 2019 | 5223 | 0.070 |
Why?
|
| Models, Statistical | 3 | 2018 | 5103 | 0.070 |
Why?
|
| Social Class | 1 | 2015 | 2000 | 0.070 |
Why?
|
| Peripheral Nervous System Diseases | 4 | 1997 | 716 | 0.070 |
Why?
|
| Social Support | 4 | 1990 | 2195 | 0.070 |
Why?
|
| Cerebrovascular Circulation | 1 | 2016 | 2737 | 0.070 |
Why?
|
| Ambulatory Care | 3 | 2006 | 2780 | 0.070 |
Why?
|
| Clozapine | 3 | 2002 | 508 | 0.070 |
Why?
|
| Cell Adhesion | 1 | 2012 | 3103 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2019 | 19041 | 0.060 |
Why?
|
| Brain Edema | 1 | 1990 | 608 | 0.060 |
Why?
|
| Avoidance Learning | 2 | 2005 | 249 | 0.060 |
Why?
|
| Linguistics | 1 | 2006 | 110 | 0.060 |
Why?
|
| DNA Damage | 1 | 2015 | 2461 | 0.060 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2009 | 794 | 0.060 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2015 | 2823 | 0.060 |
Why?
|
| Nervous System Diseases | 1 | 2015 | 1668 | 0.060 |
Why?
|
| Adipocytes | 1 | 2012 | 1199 | 0.060 |
Why?
|
| Delivery of Health Care | 2 | 2020 | 5367 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2019 | 3612 | 0.060 |
Why?
|
| Perinatology | 1 | 2004 | 63 | 0.060 |
Why?
|
| Body Mass Index | 2 | 2020 | 13030 | 0.060 |
Why?
|
| Developmental Disabilities | 1 | 2013 | 1516 | 0.060 |
Why?
|
| Estrogens | 1 | 2011 | 1531 | 0.060 |
Why?
|
| Age of Onset | 4 | 2015 | 3342 | 0.060 |
Why?
|
| Neurons | 3 | 2014 | 9504 | 0.060 |
Why?
|
| Disease Progression | 3 | 2019 | 13655 | 0.060 |
Why?
|
| Emotions | 3 | 2021 | 2773 | 0.060 |
Why?
|
| Body Weight | 2 | 2012 | 4630 | 0.060 |
Why?
|
| Myelin Proteins | 2 | 1994 | 212 | 0.060 |
Why?
|
| Pattern Recognition, Automated | 1 | 2010 | 998 | 0.050 |
Why?
|
| Chronic Disease | 9 | 2014 | 9382 | 0.050 |
Why?
|
| Verbal Behavior | 2 | 2004 | 336 | 0.050 |
Why?
|
| Parabiosis | 1 | 2023 | 65 | 0.050 |
Why?
|
| Lead | 1 | 2008 | 880 | 0.050 |
Why?
|
| Double-Blind Method | 6 | 1996 | 12450 | 0.050 |
Why?
|
| Dementia | 1 | 2017 | 2723 | 0.050 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2006 | 708 | 0.050 |
Why?
|
| Hostility | 1 | 2003 | 185 | 0.050 |
Why?
|
| Tourette Syndrome | 2 | 1996 | 400 | 0.050 |
Why?
|
| Linear Models | 3 | 2007 | 5880 | 0.050 |
Why?
|
| Schizophrenia, Paranoid | 2 | 1994 | 103 | 0.050 |
Why?
|
| Gene Knockdown Techniques | 2 | 2019 | 1608 | 0.050 |
Why?
|
| Tooth, Deciduous | 1 | 2021 | 76 | 0.050 |
Why?
|
| Cocaine-Related Disorders | 1 | 2004 | 461 | 0.050 |
Why?
|
| Nuclear Family | 2 | 2004 | 311 | 0.050 |
Why?
|
| MicroRNAs | 2 | 2014 | 3805 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 2 | 2023 | 2003 | 0.050 |
Why?
|
| Reproducibility of Results | 7 | 2020 | 20231 | 0.050 |
Why?
|
| Eating | 2 | 2021 | 1538 | 0.050 |
Why?
|
| Sex Distribution | 1 | 2006 | 2286 | 0.050 |
Why?
|
| Mental Fatigue | 1 | 2000 | 23 | 0.040 |
Why?
|
| Psychomotor Agitation | 1 | 2003 | 307 | 0.040 |
Why?
|
| Multivariate Analysis | 3 | 2006 | 12096 | 0.040 |
Why?
|
| Receptors, Muscarinic | 1 | 2000 | 157 | 0.040 |
Why?
|
| Risperidone | 1 | 2002 | 383 | 0.040 |
Why?
|
| Muscle Fatigue | 1 | 2000 | 96 | 0.040 |
Why?
|
| Tegmentum Mesencephali | 1 | 1980 | 59 | 0.040 |
Why?
|
| Gait | 2 | 2015 | 822 | 0.040 |
Why?
|
| Patient Readmission | 4 | 1989 | 3308 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2014 | 9507 | 0.040 |
Why?
|
| Receptors, Cholinergic | 1 | 2000 | 244 | 0.040 |
Why?
|
| Probability | 3 | 2011 | 2483 | 0.040 |
Why?
|
| Markov Chains | 2 | 2018 | 977 | 0.040 |
Why?
|
| Septal Nuclei | 1 | 1980 | 84 | 0.040 |
Why?
|
| Quality of Life | 1 | 2001 | 13497 | 0.040 |
Why?
|
| Benzodiazepines | 2 | 2002 | 1139 | 0.040 |
Why?
|
| Algorithms | 5 | 2018 | 14158 | 0.040 |
Why?
|
| Respiratory Rate | 1 | 2020 | 180 | 0.040 |
Why?
|
| Personnel Management | 1 | 1999 | 54 | 0.040 |
Why?
|
| Models, Biological | 2 | 2012 | 9505 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2003 | 4077 | 0.040 |
Why?
|
| Acute Disease | 3 | 2016 | 7246 | 0.040 |
Why?
|
| Time Factors | 3 | 2012 | 40271 | 0.040 |
Why?
|
| Efficiency | 1 | 2002 | 477 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2013 | 6429 | 0.040 |
Why?
|
| Germany | 1 | 2020 | 882 | 0.040 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2007 | 3742 | 0.040 |
Why?
|
| Retrospective Studies | 12 | 2018 | 81834 | 0.040 |
Why?
|
| Auditory Perception | 2 | 2004 | 588 | 0.040 |
Why?
|
| Volition | 1 | 1998 | 61 | 0.040 |
Why?
|
| Inflammation | 1 | 2018 | 10865 | 0.040 |
Why?
|
| Migraine Disorders | 1 | 1990 | 1713 | 0.040 |
Why?
|
| Treatment Outcome | 6 | 2019 | 65409 | 0.040 |
Why?
|
| Sulfoglycosphingolipids | 1 | 1997 | 31 | 0.040 |
Why?
|
| Myosin Heavy Chains | 1 | 2019 | 404 | 0.040 |
Why?
|
| Occipital Lobe | 1 | 1999 | 376 | 0.040 |
Why?
|
| Psychometrics | 5 | 2010 | 3072 | 0.040 |
Why?
|
| Nucleus Accumbens | 1 | 1980 | 372 | 0.040 |
Why?
|
| Odds Ratio | 4 | 2015 | 9687 | 0.040 |
Why?
|
| Apomorphine | 2 | 1993 | 150 | 0.030 |
Why?
|
| Concept Formation | 1 | 1998 | 162 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2010 | 3826 | 0.030 |
Why?
|
| Vocabulary | 1 | 1997 | 167 | 0.030 |
Why?
|
| Polychlorinated Biphenyls | 1 | 2018 | 236 | 0.030 |
Why?
|
| Amino Acids | 1 | 2023 | 1714 | 0.030 |
Why?
|
| Dietary Carbohydrates | 1 | 2021 | 896 | 0.030 |
Why?
|
| Substance-Related Disorders | 2 | 2010 | 4453 | 0.030 |
Why?
|
| Antibodies | 2 | 1994 | 2425 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 11930 | 0.030 |
Why?
|
| Immunoglobulin M | 3 | 1997 | 1529 | 0.030 |
Why?
|
| Muscle Tonus | 1 | 2015 | 82 | 0.030 |
Why?
|
| Discrimination Learning | 1 | 1997 | 278 | 0.030 |
Why?
|
| Endophenotypes | 1 | 2017 | 258 | 0.030 |
Why?
|
| Smell | 1 | 1997 | 261 | 0.030 |
Why?
|
| Vasomotor System | 1 | 2015 | 208 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2018 | 738 | 0.030 |
Why?
|
| Seasons | 2 | 1992 | 1526 | 0.030 |
Why?
|
| Aggression | 1 | 1980 | 750 | 0.030 |
Why?
|
| Mutation | 1 | 2019 | 30243 | 0.030 |
Why?
|
| Infant, Low Birth Weight | 1 | 2000 | 875 | 0.030 |
Why?
|
| Horses | 1 | 2015 | 296 | 0.030 |
Why?
|
| Fertility | 1 | 2019 | 772 | 0.030 |
Why?
|
| Receptors, Androgen | 1 | 2001 | 1084 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2019 | 1972 | 0.030 |
Why?
|
| Lumbosacral Region | 1 | 1996 | 294 | 0.030 |
Why?
|
| Adaptation, Psychological | 1 | 2005 | 2665 | 0.030 |
Why?
|
| Community Mental Health Services | 2 | 1990 | 389 | 0.030 |
Why?
|
| Receptors, Serotonin | 1 | 1995 | 209 | 0.030 |
Why?
|
| Lymphocytosis | 1 | 1995 | 121 | 0.030 |
Why?
|
| Hypertrophy | 1 | 1996 | 562 | 0.030 |
Why?
|
| Rats | 4 | 2015 | 23839 | 0.030 |
Why?
|
| Naloxone | 1 | 1977 | 371 | 0.030 |
Why?
|
| Regression Analysis | 2 | 2001 | 6353 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 1988 | 3922 | 0.030 |
Why?
|
| Predictive Value of Tests | 3 | 2015 | 15460 | 0.030 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 2 | 2013 | 1994 | 0.030 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2013 | 108 | 0.030 |
Why?
|
| Monte Carlo Method | 1 | 2018 | 1262 | 0.030 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2013 | 115 | 0.030 |
Why?
|
| Interview, Psychological | 2 | 2014 | 812 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2001 | 2243 | 0.030 |
Why?
|
| Sheep | 1 | 2015 | 1451 | 0.030 |
Why?
|
| Hallucinations | 1 | 2015 | 375 | 0.030 |
Why?
|
| Attitude | 2 | 1988 | 773 | 0.030 |
Why?
|
| Intercellular Junctions | 1 | 2012 | 197 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2018 | 1021 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2014 | 560 | 0.020 |
Why?
|
| Visual Perception | 1 | 2000 | 1406 | 0.020 |
Why?
|
| Biophysical Phenomena | 1 | 2012 | 321 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2019 | 2216 | 0.020 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2019 | 1496 | 0.020 |
Why?
|
| Amphetamine | 1 | 1993 | 224 | 0.020 |
Why?
|
| Microelectrodes | 1 | 1993 | 308 | 0.020 |
Why?
|
| Ventricular Remodeling | 1 | 2019 | 1280 | 0.020 |
Why?
|
| Managed Care Programs | 1 | 1997 | 941 | 0.020 |
Why?
|
| Metagenome | 1 | 2015 | 465 | 0.020 |
Why?
|
| Dinoprostone | 1 | 2014 | 597 | 0.020 |
Why?
|
| Substantia Nigra | 1 | 1993 | 348 | 0.020 |
Why?
|
| Receptor, Notch1 | 1 | 2014 | 521 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2011 | 8201 | 0.020 |
Why?
|
| Propionates | 1 | 2011 | 180 | 0.020 |
Why?
|
| Culture Media | 1 | 2012 | 899 | 0.020 |
Why?
|
| Movement Disorders | 1 | 1994 | 464 | 0.020 |
Why?
|
| Dopamine | 2 | 1993 | 1616 | 0.020 |
Why?
|
| Normal Distribution | 1 | 2011 | 272 | 0.020 |
Why?
|
| Software | 2 | 2016 | 4463 | 0.020 |
Why?
|
| Wnt Proteins | 1 | 2014 | 724 | 0.020 |
Why?
|
| Electrophysiology | 1 | 1993 | 1266 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2012 | 808 | 0.020 |
Why?
|
| Personality Development | 1 | 1990 | 244 | 0.020 |
Why?
|
| Faculty, Medical | 1 | 2017 | 1218 | 0.020 |
Why?
|
| Personality Inventory | 1 | 2012 | 1019 | 0.020 |
Why?
|
| United States | 4 | 2015 | 73121 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2013 | 1640 | 0.020 |
Why?
|
| Depressive Disorder | 2 | 1993 | 3738 | 0.020 |
Why?
|
| Environmental Pollutants | 1 | 2018 | 1290 | 0.020 |
Why?
|
| Cytoskeleton | 1 | 2014 | 1179 | 0.020 |
Why?
|
| Diffusion | 1 | 2011 | 818 | 0.020 |
Why?
|
| Internal-External Control | 1 | 2010 | 359 | 0.020 |
Why?
|
| Anthropometry | 1 | 2013 | 1343 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2011 | 583 | 0.020 |
Why?
|
| Social Behavior | 1 | 2015 | 1144 | 0.020 |
Why?
|
| Father-Child Relations | 1 | 1988 | 48 | 0.020 |
Why?
|
| Electric Stimulation | 2 | 2006 | 1743 | 0.020 |
Why?
|
| Delivery, Obstetric | 1 | 2015 | 953 | 0.020 |
Why?
|
| Personality Assessment | 1 | 2010 | 649 | 0.020 |
Why?
|
| Autoantibodies | 1 | 1997 | 2131 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2015 | 1797 | 0.020 |
Why?
|
| DNA, Viral | 1 | 2015 | 2206 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2018 | 3234 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 1996 | 10784 | 0.020 |
Why?
|
| Aftercare | 2 | 1985 | 921 | 0.020 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2012 | 542 | 0.020 |
Why?
|
| Periodicals as Topic | 1 | 1998 | 1468 | 0.020 |
Why?
|
| Phenols | 1 | 2011 | 520 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2019 | 3080 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2024 | 6657 | 0.020 |
Why?
|
| History, 21st Century | 1 | 2013 | 1575 | 0.020 |
Why?
|
| Occupations | 1 | 2009 | 519 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2014 | 1738 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2019 | 3941 | 0.020 |
Why?
|
| Fasting | 1 | 2012 | 1608 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 1995 | 2209 | 0.020 |
Why?
|
| Nitriles | 1 | 2011 | 984 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 1995 | 2819 | 0.020 |
Why?
|
| Personnel, Hospital | 1 | 1988 | 285 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 59680 | 0.020 |
Why?
|
| Risk Assessment | 4 | 2000 | 24311 | 0.020 |
Why?
|
| Random Allocation | 1 | 1990 | 2399 | 0.020 |
Why?
|
| Motor Activity | 1 | 2015 | 2722 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2019 | 6410 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2013 | 2772 | 0.020 |
Why?
|
| Gadolinium | 1 | 1990 | 965 | 0.020 |
Why?
|
| Action Potentials | 1 | 1993 | 1837 | 0.020 |
Why?
|
| Family Characteristics | 1 | 1990 | 1002 | 0.020 |
Why?
|
| Actuarial Analysis | 1 | 1985 | 372 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2018 | 6278 | 0.020 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 1994 | 1509 | 0.010 |
Why?
|
| Proportional Hazards Models | 2 | 2006 | 12561 | 0.010 |
Why?
|
| Mother-Child Relations | 1 | 1988 | 501 | 0.010 |
Why?
|
| Galvanic Skin Response | 1 | 2006 | 359 | 0.010 |
Why?
|
| Communication | 1 | 1999 | 3910 | 0.010 |
Why?
|
| Research Support as Topic | 1 | 2009 | 699 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2020 | 8538 | 0.010 |
Why?
|
| Cerebral Ventricles | 2 | 1997 | 551 | 0.010 |
Why?
|
| Myelin-Associated Glycoprotein | 2 | 1994 | 110 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2013 | 1891 | 0.010 |
Why?
|
| Achievement | 1 | 2006 | 288 | 0.010 |
Why?
|
| Prognosis | 2 | 2019 | 30028 | 0.010 |
Why?
|
| Leptin | 1 | 2012 | 1598 | 0.010 |
Why?
|
| Mathematics | 1 | 1985 | 704 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 3437 | 0.010 |
Why?
|
| Matched-Pair Analysis | 1 | 2004 | 286 | 0.010 |
Why?
|
| Premature Birth | 1 | 2015 | 1816 | 0.010 |
Why?
|
| Deinstitutionalization | 1 | 1983 | 19 | 0.010 |
Why?
|
| Genetic Load | 1 | 2003 | 15 | 0.010 |
Why?
|
| Gene Expression | 1 | 1995 | 7605 | 0.010 |
Why?
|
| Genotype | 1 | 2017 | 13047 | 0.010 |
Why?
|
| Alcoholism | 1 | 1993 | 1993 | 0.010 |
Why?
|
| Length of Stay | 2 | 1988 | 6521 | 0.010 |
Why?
|
| Self Report | 1 | 2014 | 3771 | 0.010 |
Why?
|
| Suicide | 1 | 1993 | 1608 | 0.010 |
Why?
|
| Anxiety Disorders | 1 | 1993 | 2754 | 0.010 |
Why?
|
| Recurrence | 1 | 2014 | 8510 | 0.010 |
Why?
|
| Hyperprolactinemia | 1 | 2002 | 124 | 0.010 |
Why?
|
| Menstruation Disturbances | 1 | 2002 | 143 | 0.010 |
Why?
|
| Sensitivity and Specificity | 2 | 2010 | 14728 | 0.010 |
Why?
|
| Demography | 1 | 2006 | 1643 | 0.010 |
Why?
|
| Pyrazoles | 1 | 2011 | 2024 | 0.010 |
Why?
|
| Residence Characteristics | 1 | 1990 | 2119 | 0.010 |
Why?
|
| Body Height | 1 | 2006 | 1568 | 0.010 |
Why?
|
| Calcium | 1 | 2012 | 5793 | 0.010 |
Why?
|
| Maternal Welfare | 1 | 2000 | 113 | 0.010 |
Why?
|
| Radiography | 2 | 2004 | 6995 | 0.010 |
Why?
|
| Image Enhancement | 1 | 2010 | 2894 | 0.010 |
Why?
|
| Geniculate Bodies | 1 | 1980 | 159 | 0.010 |
Why?
|
| Signal Detection, Psychological | 1 | 1998 | 84 | 0.010 |
Why?
|
| Cats | 1 | 1980 | 978 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 1997 | 3816 | 0.010 |
Why?
|
| Apoptosis | 1 | 2014 | 9526 | 0.010 |
Why?
|
| Personality Tests | 1 | 1997 | 80 | 0.010 |
Why?
|
| Massachusetts | 1 | 1990 | 8908 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2004 | 2733 | 0.010 |
Why?
|
| Wechsler Scales | 1 | 1997 | 258 | 0.010 |
Why?
|
| Stereotyped Behavior | 1 | 1977 | 135 | 0.010 |
Why?
|
| Dextroamphetamine | 1 | 1977 | 134 | 0.010 |
Why?
|
| Neural Inhibition | 1 | 1980 | 588 | 0.010 |
Why?
|
| Dyskinesia, Drug-Induced | 1 | 1996 | 165 | 0.010 |
Why?
|
| Models, Neurological | 1 | 2004 | 1784 | 0.010 |
Why?
|
| Conditioning, Operant | 1 | 1977 | 311 | 0.010 |
Why?
|
| Sural Nerve | 1 | 1995 | 105 | 0.010 |
Why?
|
| ROC Curve | 1 | 2003 | 3624 | 0.010 |
Why?
|
| Likelihood Functions | 1 | 1998 | 993 | 0.010 |
Why?
|
| Reading | 1 | 1998 | 543 | 0.010 |
Why?
|
| Patient Compliance | 1 | 1985 | 2696 | 0.010 |
Why?
|
| Evoked Potentials | 1 | 1980 | 1057 | 0.010 |
Why?
|
| Pregnancy Outcome | 1 | 2004 | 2959 | 0.010 |
Why?
|
| Data Collection | 1 | 2003 | 3329 | 0.010 |
Why?
|
| Tic Disorders | 1 | 1994 | 140 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 1985 | 3590 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2009 | 8051 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1996 | 20762 | 0.010 |
Why?
|
| Species Specificity | 1 | 1977 | 2422 | 0.010 |
Why?
|
| Ataxia | 1 | 1994 | 307 | 0.010 |
Why?
|
| Reaction Time | 1 | 1998 | 2102 | 0.010 |
Why?
|
| Obstetric Labor Complications | 1 | 1994 | 243 | 0.010 |
Why?
|
| Patient Discharge | 1 | 1985 | 3471 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 18388 | 0.010 |
Why?
|
| Hospitalization | 1 | 1990 | 10845 | 0.010 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 1994 | 672 | 0.010 |
Why?
|
| Germany, West | 1 | 1989 | 13 | 0.010 |
Why?
|
| Artificial Intelligence | 1 | 2004 | 2659 | 0.000 |
Why?
|
| Antigens | 1 | 1994 | 1443 | 0.000 |
Why?
|
| Binding Sites | 1 | 1997 | 6030 | 0.000 |
Why?
|
| Blotting, Western | 1 | 1994 | 5042 | 0.000 |
Why?
|
| Models, Genetic | 1 | 1996 | 3442 | 0.000 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2003 | 10358 | 0.000 |
Why?
|
| Brain Diseases | 1 | 1994 | 1553 | 0.000 |
Why?
|
| Histones | 1 | 1994 | 2595 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1997 | 11138 | 0.000 |
Why?
|
| Biopsy | 1 | 1995 | 6816 | 0.000 |
Why?
|
| Brain Injuries | 1 | 1994 | 2060 | 0.000 |
Why?
|
| Databases, Factual | 1 | 1998 | 8081 | 0.000 |
Why?
|
| Nerve Tissue Proteins | 1 | 1994 | 4417 | 0.000 |
Why?
|